Case Study

For more information, or if the hyperlink has expired please contact CIB.

case_study_database

CIB Reference:

CIB-10-0036
Date:

2010-01-19
Country:

USA
Category:

Risk to consumer health and safety, Poor product quality
Sector:

Pharmaceuticals
Title

Warning on Fake Alli
Hyperlink:

Click Here
Introductiion:

The Food and Drug Administration on Monday warned consumers about a counterfeit version of GlaxoSmithKline's weight-loss drug Alli.
Full Article:

N/A
Source:

See Hyperlink